Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Cash (2016 - 2025)

Historic Change in Cash for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to -$578540.0.

  • Pharma-Bio Serv's Change in Cash fell 33406.18% to -$578540.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$3.4 million, marking a year-over-year increase of 789.83%. This contributed to the annual value of -$3.4 million for FY2025, which is 789.83% up from last year.
  • Pharma-Bio Serv's Change in Cash amounted to -$578540.0 in Q4 2025, which was down 33406.18% from $1.9 million recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Change in Cash high stood at $7.6 million for Q4 2023, and its period low was -$7.2 million during Q1 2023.
  • For the 5-year period, Pharma-Bio Serv's Change in Cash averaged around -$687935.6, with its median value being $235537.0 (2022).
  • In the last 5 years, Pharma-Bio Serv's Change in Cash crashed by 99286.38% in 2021 and then soared by 328386.33% in 2023.
  • Over the past 5 years, Pharma-Bio Serv's Change in Cash (Quarter) stood at $970175.0 in 2021, then tumbled by 76.92% to $223900.0 in 2022, then surged by 3283.86% to $7.6 million in 2023, then tumbled by 96.74% to $247174.0 in 2024, then crashed by 334.06% to -$578540.0 in 2025.
  • Its last three reported values are -$578540.0 in Q4 2025, $1.9 million for Q3 2025, and -$5.2 million during Q2 2025.